Havas Health & You names agency leadership
Chris Palmer has been named chief creative officer and chief experience officer of Havas Life Metro, Violet Aldaia has been appointed president of H4B Chelsea and Corey Cirillo was named managing director of Havas Tonic.
Heartbeat appoints VPs
Jillian Anderson has been named group creative director, David Brennan was promoted to VP and group account director, Michelle Edwards was named VP of human resources, Tiffany Marsh has been appointed VP and group account director, David Sakadelis was promoted to SVP of technology and Nancy Salerno was named VP of content services.
Fingerpaint names digital lead
Art Stiefel has joined Fingerpaint to lead the digital department in its Conshohocken, Pa., office. Previously, Stiefel was VP of digital strategy at Trajectory.
GW Pharmaceuticals names board member
David Gryska has been appointed to the board of directors of GW Pharmaceuticals. Over his career, Gryska has served as chief financial officer at Incyte, Celgene, Scios and Cardiac Pathways Corporation.
Black Diamond Therapeutics appoints medical chief
Rachel Humphrey has been named chief medical officer at Black Diamond Therapeutics, a precision oncology medicine company.
C4 Therapeutics names CEO
Andrew Hirsch has been appointed chief executive officer at biotech C4 Therapeutics. Previously, Hirsch was chief financial officer at Agios Pharmaceuticals. He is replacing Andrew Phillips, who is departing after two years as CEO.
Agios Pharmaceuticals appoints CFO
Jonathan Biller has been named chief financial officer and head of legal and corporate affairs at Agios. Biller has been with Agios since 2019. Prior to that, he worked in financial roles at Celgene.
Starton Therapeutics appoints two to board
Kenneth Anderson and Asher Chanan-Khan have been appointed to the Starton Therapeutics board of directors. Anderson is a professor at Harvard Medical School and director of the Lebow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center at the Dana-Farber Cancer Institute. Chanan-Khan is a professor of medicine and co-chairman of the Hematologic Malignancies Program at the Mayo Clinic Cancer Center Jacksonville.
The Escalator is a weekly roundup of notable people moves in the pharmaceutical and healthcare marketing industries. For submissions, email Carrie Gavit at email@example.com.